Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exercise | 53 | 2024 | 883 | 7.590 |
Why?
|
| Insulin | 27 | 2023 | 674 | 4.140 |
Why?
|
| Energy Metabolism | 25 | 2019 | 359 | 4.000 |
Why?
|
| Metformin | 10 | 2022 | 64 | 3.810 |
Why?
|
| Blood Glucose | 26 | 2023 | 461 | 2.950 |
Why?
|
| Energy Intake | 10 | 2019 | 167 | 2.550 |
Why?
|
| Insulin Resistance | 16 | 2024 | 392 | 2.370 |
Why?
|
| Hypoglycemic Agents | 7 | 2022 | 192 | 2.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2022 | 635 | 1.710 |
Why?
|
| Obesity | 13 | 2024 | 1166 | 1.480 |
Why?
|
| Glucose Intolerance | 6 | 2014 | 88 | 1.380 |
Why?
|
| Overweight | 7 | 2024 | 238 | 1.310 |
Why?
|
| Oxygen Consumption | 12 | 2013 | 206 | 1.220 |
Why?
|
| Altitude | 5 | 2017 | 14 | 1.040 |
Why?
|
| Diabetes, Gestational | 11 | 2023 | 138 | 1.030 |
Why?
|
| Adult | 54 | 2024 | 15669 | 1.010 |
Why?
|
| Hormones | 4 | 2010 | 60 | 0.980 |
Why?
|
| Hyperglycemia | 2 | 2018 | 98 | 0.980 |
Why?
|
| Carbohydrate Metabolism | 7 | 2013 | 48 | 0.960 |
Why?
|
| Prediabetic State | 2 | 2017 | 51 | 0.890 |
Why?
|
| Risk Reduction Behavior | 4 | 2020 | 121 | 0.880 |
Why?
|
| Heart Rate | 6 | 2017 | 307 | 0.830 |
Why?
|
| Healthy Lifestyle | 2 | 2020 | 27 | 0.820 |
Why?
|
| Weight Loss | 3 | 2014 | 263 | 0.820 |
Why?
|
| Female | 56 | 2024 | 30704 | 0.780 |
Why?
|
| Humans | 77 | 2024 | 59356 | 0.780 |
Why?
|
| Lipid Metabolism | 5 | 2013 | 203 | 0.750 |
Why?
|
| Military Personnel | 1 | 2022 | 97 | 0.730 |
Why?
|
| Physical Fitness | 5 | 2022 | 92 | 0.730 |
Why?
|
| Motor Activity | 5 | 2011 | 333 | 0.720 |
Why?
|
| Appetite Regulation | 2 | 2012 | 8 | 0.710 |
Why?
|
| Appetite | 2 | 2010 | 16 | 0.690 |
Why?
|
| Postmenopause | 2 | 2020 | 224 | 0.670 |
Why?
|
| Dietary Carbohydrates | 3 | 2008 | 58 | 0.660 |
Why?
|
| Exercise Therapy | 2 | 2020 | 99 | 0.630 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 54 | 0.630 |
Why?
|
| Cancer Survivors | 1 | 2020 | 79 | 0.620 |
Why?
|
| Nutritional Status | 1 | 2019 | 93 | 0.620 |
Why?
|
| Running | 2 | 2017 | 80 | 0.620 |
Why?
|
| Male | 36 | 2022 | 27738 | 0.620 |
Why?
|
| Weight Gain | 4 | 2017 | 163 | 0.600 |
Why?
|
| Glucose Tolerance Test | 8 | 2020 | 96 | 0.560 |
Why?
|
| Heart Diseases | 1 | 2019 | 206 | 0.550 |
Why?
|
| Fitness Trackers | 1 | 2017 | 19 | 0.550 |
Why?
|
| Cross-Over Studies | 6 | 2018 | 153 | 0.540 |
Why?
|
| Metabolic Syndrome | 4 | 2024 | 131 | 0.540 |
Why?
|
| Exercise Test | 7 | 2022 | 242 | 0.540 |
Why?
|
| Leptin | 4 | 2012 | 83 | 0.540 |
Why?
|
| Young Adult | 17 | 2023 | 4267 | 0.520 |
Why?
|
| Liver | 2 | 2019 | 796 | 0.520 |
Why?
|
| Body Composition | 8 | 2022 | 146 | 0.500 |
Why?
|
| Fasting | 3 | 2015 | 48 | 0.500 |
Why?
|
| Postpartum Period | 4 | 2024 | 182 | 0.500 |
Why?
|
| Cardiovascular Diseases | 4 | 2024 | 788 | 0.480 |
Why?
|
| Glucose Clamp Technique | 4 | 2011 | 57 | 0.480 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 515 | 0.480 |
Why?
|
| Social Media | 1 | 2017 | 117 | 0.470 |
Why?
|
| Ghrelin | 3 | 2012 | 18 | 0.470 |
Why?
|
| Middle Aged | 17 | 2020 | 16317 | 0.460 |
Why?
|
| Risk Factors | 14 | 2024 | 4984 | 0.450 |
Why?
|
| Glycogen | 4 | 2013 | 38 | 0.440 |
Why?
|
| Health Behavior | 7 | 2018 | 451 | 0.440 |
Why?
|
| Estrogens | 3 | 2006 | 109 | 0.440 |
Why?
|
| Workplace | 1 | 2014 | 169 | 0.410 |
Why?
|
| Progesterone | 3 | 2003 | 158 | 0.390 |
Why?
|
| Eating | 3 | 2010 | 130 | 0.380 |
Why?
|
| Pregnancy | 18 | 2024 | 2202 | 0.380 |
Why?
|
| Birth Weight | 3 | 2017 | 81 | 0.370 |
Why?
|
| Pregnancy Complications | 4 | 2020 | 364 | 0.370 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1118 | 0.370 |
Why?
|
| Glucose | 6 | 2023 | 445 | 0.360 |
Why?
|
| Adiposity | 2 | 2013 | 74 | 0.350 |
Why?
|
| Adolescent | 16 | 2022 | 5824 | 0.340 |
Why?
|
| Bicycling | 1 | 2010 | 21 | 0.330 |
Why?
|
| Body Mass Index | 8 | 2020 | 831 | 0.330 |
Why?
|
| Life Style | 6 | 2024 | 299 | 0.320 |
Why?
|
| Homeostasis | 3 | 2013 | 346 | 0.320 |
Why?
|
| Area Under Curve | 5 | 2015 | 141 | 0.320 |
Why?
|
| Diet | 3 | 2015 | 497 | 0.320 |
Why?
|
| Double-Blind Method | 6 | 2013 | 715 | 0.320 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 149 | 0.310 |
Why?
|
| Metabolism | 1 | 2008 | 12 | 0.310 |
Why?
|
| Sex Characteristics | 1 | 2010 | 197 | 0.300 |
Why?
|
| Prenatal Care | 3 | 2015 | 169 | 0.300 |
Why?
|
| Adaptation, Physiological | 2 | 2008 | 117 | 0.300 |
Why?
|
| Oxidation-Reduction | 5 | 2010 | 302 | 0.290 |
Why?
|
| Food | 1 | 2008 | 76 | 0.290 |
Why?
|
| Walking | 3 | 2018 | 228 | 0.290 |
Why?
|
| Postprandial Period | 2 | 2018 | 18 | 0.270 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 1561 | 0.270 |
Why?
|
| Massachusetts | 8 | 2024 | 2003 | 0.270 |
Why?
|
| C-Reactive Protein | 3 | 2015 | 159 | 0.270 |
Why?
|
| Respiration | 1 | 2006 | 88 | 0.260 |
Why?
|
| Cardiovascular System | 1 | 2006 | 38 | 0.260 |
Why?
|
| Time Factors | 8 | 2011 | 3617 | 0.250 |
Why?
|
| Rest | 2 | 2002 | 44 | 0.250 |
Why?
|
| Fetal Macrosomia | 2 | 2015 | 12 | 0.250 |
Why?
|
| Androgens | 1 | 2005 | 47 | 0.240 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2016 | 35 | 0.240 |
Why?
|
| Testosterone | 1 | 2005 | 112 | 0.230 |
Why?
|
| Postnatal Care | 2 | 2015 | 38 | 0.230 |
Why?
|
| Biomarkers | 5 | 2024 | 1306 | 0.230 |
Why?
|
| Muscle, Skeletal | 2 | 2010 | 674 | 0.220 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 84 | 0.210 |
Why?
|
| Feeding Behavior | 2 | 2015 | 254 | 0.200 |
Why?
|
| Body Weight | 5 | 2019 | 368 | 0.190 |
Why?
|
| Pregnancy Outcome | 3 | 2018 | 181 | 0.190 |
Why?
|
| Calorimetry, Indirect | 2 | 2013 | 31 | 0.190 |
Why?
|
| Anaerobic Threshold | 2 | 2013 | 12 | 0.180 |
Why?
|
| Firefighters | 1 | 2020 | 1 | 0.180 |
Why?
|
| Occupational Stress | 1 | 2020 | 19 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2011 | 68 | 0.170 |
Why?
|
| Fatigue | 1 | 2020 | 103 | 0.170 |
Why?
|
| Lipids | 2 | 2015 | 300 | 0.170 |
Why?
|
| Protective Factors | 1 | 2019 | 33 | 0.160 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2019 | 6 | 0.160 |
Why?
|
| Rodentia | 1 | 2019 | 21 | 0.160 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 75 | 0.160 |
Why?
|
| Physical Conditioning, Animal | 1 | 2019 | 38 | 0.160 |
Why?
|
| Meals | 1 | 2018 | 23 | 0.160 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2013 | 56 | 0.150 |
Why?
|
| Monitoring, Ambulatory | 2 | 2009 | 56 | 0.150 |
Why?
|
| Absorptiometry, Photon | 2 | 2008 | 74 | 0.140 |
Why?
|
| Aging | 1 | 2003 | 710 | 0.140 |
Why?
|
| Random Allocation | 1 | 2017 | 192 | 0.130 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2008 | 43 | 0.130 |
Why?
|
| Cesarean Section | 1 | 2017 | 95 | 0.130 |
Why?
|
| Lactic Acid | 2 | 2010 | 71 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 355 | 0.130 |
Why?
|
| Puerto Rico | 4 | 2020 | 134 | 0.130 |
Why?
|
| Placebos | 2 | 2008 | 68 | 0.130 |
Why?
|
| Diabetic Angiopathies | 1 | 2016 | 24 | 0.130 |
Why?
|
| Caloric Restriction | 2 | 2005 | 16 | 0.120 |
Why?
|
| Health Education | 2 | 2014 | 182 | 0.120 |
Why?
|
| Data Collection | 1 | 2017 | 371 | 0.120 |
Why?
|
| Health Promotion | 2 | 2017 | 471 | 0.120 |
Why?
|
| Aged | 4 | 2020 | 13416 | 0.120 |
Why?
|
| Prospective Studies | 7 | 2020 | 3067 | 0.120 |
Why?
|
| Sex Factors | 3 | 2008 | 935 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2016 | 279 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2010 | 589 | 0.110 |
Why?
|
| Kinetics | 2 | 2007 | 751 | 0.110 |
Why?
|
| Anxiety | 2 | 2020 | 387 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2013 | 21 | 0.110 |
Why?
|
| Anthropometry | 1 | 2013 | 78 | 0.100 |
Why?
|
| Foot | 1 | 2013 | 41 | 0.100 |
Why?
|
| Algorithms | 2 | 2008 | 976 | 0.100 |
Why?
|
| Resistance Training | 1 | 2013 | 19 | 0.100 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 71 | 0.100 |
Why?
|
| Epinephrine | 2 | 2002 | 41 | 0.100 |
Why?
|
| Animals | 4 | 2019 | 19648 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2013 | 289 | 0.090 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 259 | 0.090 |
Why?
|
| Triglycerides | 1 | 2013 | 231 | 0.090 |
Why?
|
| Hypertension | 1 | 2016 | 568 | 0.090 |
Why?
|
| Affect | 1 | 2011 | 123 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2013 | 495 | 0.090 |
Why?
|
| Self Efficacy | 1 | 2011 | 194 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5284 | 0.080 |
Why?
|
| Menstrual Cycle | 3 | 2006 | 81 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 584 | 0.080 |
Why?
|
| Thyroid Hormones | 1 | 2008 | 74 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2008 | 42 | 0.070 |
Why?
|
| Electron Transport Complex I | 1 | 2008 | 15 | 0.070 |
Why?
|
| Glycerol | 1 | 2007 | 31 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2008 | 111 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2008 | 173 | 0.070 |
Why?
|
| Catecholamines | 2 | 2006 | 29 | 0.070 |
Why?
|
| Hypoxia | 1 | 2008 | 112 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2010 | 884 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1093 | 0.070 |
Why?
|
| Depression | 1 | 2013 | 828 | 0.070 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2006 | 13 | 0.070 |
Why?
|
| Physical Endurance | 1 | 2006 | 45 | 0.070 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2006 | 26 | 0.070 |
Why?
|
| Joint Instability | 1 | 2006 | 39 | 0.070 |
Why?
|
| Physical Exertion | 1 | 2006 | 79 | 0.070 |
Why?
|
| Hyperphagia | 1 | 2006 | 18 | 0.060 |
Why?
|
| Athletic Injuries | 1 | 2006 | 71 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2005 | 47 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2005 | 12 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 63 | 0.060 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2005 | 86 | 0.060 |
Why?
|
| Research Design | 1 | 2008 | 555 | 0.060 |
Why?
|
| Osteoarthritis, Knee | 1 | 2010 | 380 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2006 | 310 | 0.060 |
Why?
|
| Dominican Republic | 2 | 2014 | 21 | 0.060 |
Why?
|
| Surveys and Questionnaires | 4 | 2015 | 2513 | 0.060 |
Why?
|
| Antioxidants | 1 | 2006 | 241 | 0.060 |
Why?
|
| Knee Joint | 1 | 2006 | 285 | 0.060 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2003 | 15 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 741 | 0.050 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2003 | 77 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 588 | 0.050 |
Why?
|
| Motivation | 2 | 2015 | 273 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2002 | 98 | 0.050 |
Why?
|
| Logistic Models | 2 | 2017 | 1232 | 0.050 |
Why?
|
| United States | 3 | 2014 | 7390 | 0.050 |
Why?
|
| Models, Animal | 1 | 2002 | 221 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 689 | 0.050 |
Why?
|
| Muscles | 1 | 2002 | 173 | 0.050 |
Why?
|
| Sports Medicine | 2 | 2010 | 22 | 0.040 |
Why?
|
| Ecological Momentary Assessment | 1 | 2020 | 5 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2002 | 190 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2002 | 283 | 0.040 |
Why?
|
| Proteins | 1 | 2005 | 730 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 441 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 190 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2011 | 525 | 0.040 |
Why?
|
| Incidence | 2 | 2014 | 1237 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 2374 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 574 | 0.040 |
Why?
|
| Gestational Age | 1 | 2018 | 178 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 914 | 0.030 |
Why?
|
| Counseling | 2 | 2009 | 349 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 745 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 2016 | 69 | 0.030 |
Why?
|
| Rats | 1 | 2019 | 1910 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2015 | 45 | 0.030 |
Why?
|
| Patient Education as Topic | 2 | 2009 | 454 | 0.030 |
Why?
|
| Health Status | 1 | 2017 | 424 | 0.030 |
Why?
|
| Weight Reduction Programs | 1 | 2015 | 55 | 0.030 |
Why?
|
| Goals | 1 | 2014 | 88 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2013 | 25 | 0.030 |
Why?
|
| Strikes, Employee | 1 | 2013 | 3 | 0.030 |
Why?
|
| Shoes | 1 | 2013 | 13 | 0.030 |
Why?
|
| Poverty | 1 | 2015 | 281 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2013 | 39 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2050 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 902 | 0.020 |
Why?
|
| Maternal Welfare | 1 | 2011 | 15 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 313 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 481 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 409 | 0.020 |
Why?
|
| Pregnant Women | 1 | 2011 | 84 | 0.020 |
Why?
|
| Health Surveys | 1 | 2011 | 298 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 256 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2013 | 442 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 470 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 242 | 0.020 |
Why?
|
| Self Report | 1 | 2011 | 359 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2009 | 59 | 0.020 |
Why?
|
| Women's Health | 1 | 2011 | 360 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 264 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1051 | 0.020 |
Why?
|
| Perception | 1 | 2008 | 167 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2006 | 85 | 0.020 |
Why?
|
| Self Care | 1 | 2008 | 207 | 0.020 |
Why?
|
| Pain | 1 | 2009 | 396 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2005 | 27 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2005 | 17 | 0.020 |
Why?
|
| Nitrogen | 1 | 2005 | 24 | 0.020 |
Why?
|
| Calorimetry | 1 | 2005 | 40 | 0.020 |
Why?
|
| Leucine | 1 | 2005 | 61 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 1921 | 0.010 |
Why?
|
| Plasma Volume | 1 | 2003 | 4 | 0.010 |
Why?
|
| Phenylephrine | 1 | 2003 | 14 | 0.010 |
Why?
|
| Prazosin | 1 | 2003 | 9 | 0.010 |
Why?
|
| Acclimatization | 1 | 2003 | 10 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2003 | 20 | 0.010 |
Why?
|
| Basal Metabolism | 1 | 2003 | 23 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 34 | 0.010 |
Why?
|
| Estradiol | 1 | 2003 | 247 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 2373 | 0.010 |
Why?
|